Literature DB >> 19349150

Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.

Tsutomu Takahashi1, Stephen J Wood, Alison R Yung, Lisa J Phillips, Bridget Soulsby, Patrick D McGorry, Ryoichiro Tanino, Shi-Yu Zhou, Michio Suzuki, Dennis Velakoulis, Christos Pantelis.   

Abstract

Morphologic abnormalities of the insular cortex have been described in psychotic disorders such as schizophrenia, but it remains unclear whether these changes predate the onset of psychosis or develop progressively over the course of illness. In this study, we used magnetic resonance imaging to investigate the gray matter volume of the long and short insular cortices in 97 neuroleptic-naïve individuals at ultra-high-risk (UHR) for developing psychosis [of whom 31 (32%) later developed psychosis (UHR-P) and 66 (68%) did not (UHR-NP)] and 55 age- and gender-matched healthy comparisons. We also conducted a longitudinal comparison of the insular cortex gray matter changes in 31 UHR individuals (20 UHR-NP and 11 UHR-P) and 20 controls for whom follow-up MRI data between 1 and 4 years later were available. In the cross-sectional comparison, the UHR-P subjects had a significantly smaller insular cortex compared with the UHR-NP subjects bilaterally and with the controls on the right hemisphere, especially for the short insular region. More severe negative symptoms in UHR-P subjects at baseline were associated with smaller volumes of the right long insular cortex. In the longitudinal comparison, the UHR-P subjects showed greater gray matter reduction of insular cortex bilaterally (-5.0%/year) compared with controls (-0.4%/year) or UHR-NP subjects (-0.6%/year). Our findings suggest that insular cortex gray matter abnormalities in psychotic disorders may reflect pre-existing vulnerability, but that there are also active progressive changes of the insular cortex during the transition period into psychosis. Whether these longitudinal changes are features of the disorder or related to treatment with antipsychotic medication remains to be determined.

Entities:  

Mesh:

Year:  2009        PMID: 19349150     DOI: 10.1016/j.schres.2009.03.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  59 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

3.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

Review 4.  Brain imaging during the transition from psychosis prodrome to schizophrenia.

Authors:  Yoonho Chung; Tyrone D Cannon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

5.  Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders.

Authors:  Yoonho Chung; Aron Jacobson; George He; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen; Tyrone D Cannon
Journal:  Mol Neuropsychiatry       Date:  2015-05-01

6.  Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.

Authors:  Paola Dazzan; Bridget Soulsby; Andrea Mechelli; Stephen J Wood; Dennis Velakoulis; Lisa J Phillips; Alison R Yung; Xavier Chitnis; Ashleigh Lin; Robin M Murray; Patrick D McGorry; Philip K McGuire; Christos Pantelis
Journal:  Schizophr Bull       Date:  2011-04-25       Impact factor: 9.306

Review 7.  Age of onset of schizophrenia: perspectives from structural neuroimaging studies.

Authors:  Nitin Gogtay; Nora S Vyas; Renee Testa; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2011-05       Impact factor: 9.306

8.  The relationship between regional and inter-regional functional connectivity deficits in schizophrenia.

Authors:  Andrew Zalesky; Alex Fornito; Gary F Egan; Christos Pantelis; Edward T Bullmore
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

Review 9.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 10.  Brain Biomarkers of Vulnerability and Progression to Psychosis.

Authors:  Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.